Skip to main content
Hugel, Inc. logo

Hugel, Inc. — Investor Relations & Filings

Ticker · 145020 ISIN · KR7145020004 KO Manufacturing
Filings indexed 499 across all filing types
Latest filing 2024-05-02 Report Publication Anno…
Country KR South Korea
Listing KO 145020

About Hugel, Inc.

https://www.hugel-inc.com/

Hugel, Inc. is a global biopharmaceutical company specializing in the medical aesthetics and therapeutics market. The company develops, manufactures, and distributes a portfolio of high-quality products, including its flagship botulinum toxin type A formulations, known commercially as Botulax and Letybo. Its product line also features a range of hyaluronic acid (HA) fillers and PDO threads. Recognized as a leader in its field, Hugel is focused on providing innovative, efficient, and proven solutions to medical professionals worldwide. The company is committed to advancing aesthetic medicine through continuous research and development to create effective and reliable treatments.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a short announcement (884 characters) regarding an upcoming investor relations (IR) event (a conference call) to discuss Q1 2024 financial results. It provides the date, time, and location of the event, and mentions that materials will be posted on the company website. Per the 'Menu vs Meal' rule, this is an announcement of an event/report rather than the report itself, and it fits the definition of a Report Publication Announcement (RPA) or a general regulatory filing regarding an IR event.
2024-05-02 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as the 5% rule filing). It details the change in shareholding percentage by Massachusetts Financial Services Company in Hugel, Inc. due to market transactions. This falls under the category of Major Shareholding Notification.
2024-04-09 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of a General Meeting of Shareholders (Annual General Meeting). It details the approval of financial statements, director appointments, and other agenda items voted upon during the meeting held on March 29, 2024. This falls under the category of Declaration of Voting Results.
2024-03-29 Korean
기타경영사항(자율공시) (약사법 위반 1심 판결에 대한 피고 항소의 건)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from Hugel regarding an appeal against a first-instance court ruling concerning a violation of the Pharmaceutical Affairs Act. It details the legal proceedings, the parties involved, and the company's decision to appeal. Since this document pertains to significant legal matters and litigation updates, it falls under the 'Legal Proceedings Report' category.
2024-03-28 Korean
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Korean financial authorities (Financial Services Commission/Korea Exchange) regarding the decision to enter into a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 체결 결정). This is a direct announcement of a company buying back its own shares through a trust, which falls under the 'Transaction in Own Shares' category.
2024-03-27 Korean
투자판단관련주요경영사항 (약사법 위반에 대한 선고 결과)
Legal Proceedings Report Classification · 100% confidence The document is a formal disclosure regarding a court ruling (a fine for violation of the Pharmaceutical Affairs Act) involving the company and its employees. This falls under the category of legal proceedings, regulatory actions, or significant legal matters involving the company. According to the provided definitions, 'Legal Proceedings Report' (LTR) is the appropriate classification for updates on significant lawsuits or regulatory actions.
2024-03-25 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.